Affiliations and Interactions


Dr. David Brenner, Ph.D., D. Sc.

Member of NASA Specialized Center of Research on gastrointestinal carcinogenesis.

Director, Center for Radiological Research

Director, Center for High Throughput Minimally Invasive Radiation Biodosimetry (U19)

Dr. Brenner focuses on developing mechanistic models for the effects of ionizing radiation on living systems, both at the chromosomal and the animal (or human) levels.


Carole Yauk, PhD

Lead Scientist, Genomics Laboratory, Health Canada, Ottawa

Adjunct Professor of Biology, Carleton University, Ottawa

Dr. Yauk's Lab

Dr. Yauk's Lab

Dr. Yauk’s research focuses primarily on the use of genomics and other novel approaches to improve human health risk assessment for chemical exposures. Applications of genomics in her laboratory include hazard identification (using in vitro models), mode of action analysis, risk assessment, and identifying and assessing heritable genetic hazards.


Our transcriptomics team and ILSI/HESI have had a long-standing collaboration and is the member of HESI eStar Committee (previously known as HESI Genomics Committee) since 2008. HESI is a nonprofit organization with the mission to engage scientists from academia, government, industry, research, and non-governmental organizations to identify and resolve global health and environmental issues. Working through the HESI eStar Committee, we have submitted our genotoxicity biomarker, TGx-DDI, to the US FDA Biomarker Qualification Program.


Dr. Thomas Hartung

An important focus is the translation of concepts of evidence-based medicine to toxicology (evidence-based toxicology). This aims for systematic assessment of the quality of all tools for regulatory toxicology and the development of new approaches based on annotated pathways of toxicity (the Human Toxome). CAAT


Dr. Mohammed Hussein Al-Qahtani

Dr. Adel Mohammed Abuzenadah

Dr. Adeel G. Chaudhary

Saudi Society for Genomics and Molecular Oncology (SSGMO)

A leading organization in Saudi Arabia dedicated to recognizing and acknowledging advances in genomic and molecular research in Oncology with the aim of promoting cutting edge innovative research in the region and beyond.


Paul Meltzer, M.D., Ph.D.

Member of NASA Specialized Center of Research on gastrointestinal carcinogenesis.

Dr. Meltzer is a leader in the application of genome science to cancer research. His recent studies investigate the genetic and epigenetic basis of cancers in adult and pediatric patients, particularly those with bone and soft tissue sarcomas. Dr. Meltzer's long-term goal is to improve diagnosis and therapy through better understanding of the mechanisms driving tumor growth.


Dr. Vouros, Dr. Coy

Dr. Vouros and Dr. Coy are focusing on the application of DMS-MD technology in the rapid quantification of metabolites from biofluids for radiation biodosimetry purposes.

Vouros Group


Jonathan Braun, M.D., Ph.D.

Jonathan Braun, M.D., Ph.D., is a physician-researcher devoted to the roles of the immune system in resistance and susceptibility to inflammatory bowel disease and cancer.



Jerry Shay, Ph.D.

Member of NASA Specialized Center of Research on gastrointestinal carcinogenesis.